Home / Stocks / PHAT

PHAT insider trading

Phathom Pharmaceuticals, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
7
Bought · 24 mo
$441k
Buys · last 90 days
0 · $0
Most recent buy
2025-05-23

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-05-23Topper James N
Director
Bought3,780$3.86$15k
2025-05-15Topper James N
Director
Bought7,420$3.30$24k
2025-05-13Topper James N
Director
Bought48,203$3.17$153k
2025-05-08Parikh Asit
Director
Bought10,000$2.50$25k
2025-03-17Parikh Asit
Director
Bought10,000$4.42$44k
2024-12-16KARBE FRANK
Director
Bought12,500$7.93$99k
2024-12-16Parikh Asit
Director
Bought10,000$8.12$81k

Most active insider buyers

InsiderRoleBuysTotal bought
Topper James NDirector3$192k
Parikh AsitDirector3$150k
KARBE FRANKDirector1$99k

See PHAT on the chart

Every insider buy and sell for PHAT plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.